NHS Framework Agreement for the supply of Icatibant and C1 Esterase products for the treatment of Hereditary Angioedema
Estimated value
£72.0m
Awarded value
£72.0m
Awarded 19 Jun 2018
Suppliers
1
Lots
1
1 awarded
Published
16 Jul 2018
Deadline 28 Mar 2018
Awarded suppliers· 1 supplier
Awarded 19 Jun 2018 · Contract period 30 Jun 2018 — 29 Jun 2019
Award value
£72.0m